학술논문

Polygenic risk modeling for prediction of epithelial ovarian cancer risk
Document Type
article
Author
Dareng, Eileen OTyrer, Jonathan PBarnes, Daniel RJones, Michelle RYang, XinAben, Katja KHAdank, Muriel AAgata, SimonaAndrulis, Irene LAnton-Culver, HodaAntonenkova, Natalia NAravantinos, GerasimosArun, Banu KAugustinsson, AnnelieBalmaña, JudithBandera, Elisa VBarkardottir, Rosa BBarrowdale, DanielBeckmann, Matthias WBeeghly-Fadiel, AliciaBenitez, JavierBermisheva, MarinaBernardini, Marcus QBjorge, LineBlack, AmandaBogdanova, Natalia VBonanni, BernardoBorg, AkeBrenton, James DBudzilowska, AgnieszkaButzow, RalfBuys, Saundra SCai, HuiCaligo, Maria ACampbell, IanCannioto, RikkiCassingham, HayleyChang-Claude, JennyChanock, Stephen JChen, KexinChiew, Yoke-EngChung, Wendy KClaes, Kathleen BMColonna, SarahCook, Linda SCouch, Fergus JDaly, Mary BDao, FannyDavies, Eleanorde la Hoya, Miguelde Putter, RobinDennis, JoeDePersia, AllisonDevilee, PeterDiez, OrlandDing, Yuan ChunDoherty, Jennifer ADomchek, Susan MDörk, Thilodu Bois, AndreasDürst, MatthiasEccles, Diana MEliassen, Heather AEngel, ChristophEvans, Gareth DFasching, Peter AFlanagan, James MFortner, Renée TMachackova, EvaFriedman, EitanGanz, Patricia AGarber, JudyGensini, FrancescaGiles, Graham GGlendon, GordGodwin, Andrew KGoodman, Marc TGreene, Mark HGronwald, JacekHahnen, EricHaiman, Christopher AHåkansson, NiclasHamann, UteHansen, Thomas VOHarris, Holly RHartman, MikaelHeitz, FlorianHildebrandt, Michelle ATHøgdall, EstridHøgdall, Claus KHopper, John LHuang, Ruea-YeaHuff, ChadHulick, Peter JHuntsman, David GImyanitov, Evgeny NIsaacs, ClaudineJakubowska, AnnaJames, Paul AJanavicius, Ramunas
Source
European Journal of Human Genetics. 30(3)
Subject
Prevention
Cancer
Ovarian Cancer
Rare Diseases
Good Health and Well Being
Bayes Theorem
Breast Neoplasms
Carcinoma
Ovarian Epithelial
Female
Genetic Predisposition to Disease
Humans
Male
Ovarian Neoplasms
Polymorphism
Single Nucleotide
Prospective Studies
Risk Factors
GEMO Study Collaborators
GC-HBOC Study Collaborators
EMBRACE Collaborators
OPAL Study Group
AOCS Group
KConFab Investigators
HEBON Investigators
OCAC Consortium
CIMBA Consortium
Genetics
Clinical Sciences
Genetics & Heredity
Language
Abstract
Polygenic risk scores (PRS) for epithelial ovarian cancer (EOC) have the potential to improve risk stratification. Joint estimation of Single Nucleotide Polymorphism (SNP) effects in models could improve predictive performance over standard approaches of PRS construction. Here, we implemented computationally efficient, penalized, logistic regression models (lasso, elastic net, stepwise) to individual level genotype data and a Bayesian framework with continuous shrinkage, "select and shrink for summary statistics" (S4), to summary level data for epithelial non-mucinous ovarian cancer risk prediction. We developed the models in a dataset consisting of 23,564 non-mucinous EOC cases and 40,138 controls participating in the Ovarian Cancer Association Consortium (OCAC) and validated the best models in three populations of different ancestries: prospective data from 198,101 women of European ancestries; 7,669 women of East Asian ancestries; 1,072 women of African ancestries, and in 18,915 BRCA1 and 12,337 BRCA2 pathogenic variant carriers of European ancestries. In the external validation data, the model with the strongest association for non-mucinous EOC risk derived from the OCAC model development data was the S4 model (27,240 SNPs) with odds ratios (OR) of 1.38 (95% CI: 1.28-1.48, AUC: 0.588) per unit standard deviation, in women of European ancestries; 1.14 (95% CI: 1.08-1.19, AUC: 0.538) in women of East Asian ancestries; 1.38 (95% CI: 1.21-1.58, AUC: 0.593) in women of African ancestries; hazard ratios of 1.36 (95% CI: 1.29-1.43, AUC: 0.592) in BRCA1 pathogenic variant carriers and 1.49 (95% CI: 1.35-1.64, AUC: 0.624) in BRCA2 pathogenic variant carriers. Incorporation of the S4 PRS in risk prediction models for ovarian cancer may have clinical utility in ovarian cancer prevention programs.